Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing

Carolina Wealth Advisors, LLC disclosed in an Oct. 7, 2025, U.S. Securities and Exchange Commission filing that it sold 38,267 AbbVie shares for the quarter ended Sept. 30, 2025, an estimated $7.79 million trade based on quarterly average pricing.According to a filing with the U.S. Securities and Exchange Commission dated Oct. 7, 2025, Carolina Wealth Advisors, LLC reduced its stake in AbbVie (NYSE:ABBV) during the third quarter, selling 38,267 shares. The estimated value of shares sold was approximately $7.79 million, calculated using the average closing price for the quarter. The fund reported holding 620 shares at quarter-end.The fund’s direction was a sale; AbbVie now accounts for 0.0620% of 13F assets under managementContinue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool